Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Dreyfus currently holds 10,958 shares of IRONWOOD PHARMACEUTICALS INC (IRWD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Dreyfus has been a net neutral trader of IRWD stock. They have purchased $0 and sold $0 worth of shares.
Andrew Dreyfus's most recent insider trade was on May 12, 2026, when they sold 10,958 shares at $0.00 per share.
Andrew Dreyfus serves as Executive at IRONWOOD PHARMACEUTICALS INC (IRWD). They have executed 23 insider transactions totaling $0 over their tenure at the company.
Andrew Dreyfus holds the position of Executive at IRONWOOD PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Andrew Dreyfus has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Andrew Dreyfus was on May 12, 2026, when they purchased $0 worth of ANRO shares. This transaction involved 10,958 shares at N/A per share.
Andrew Dreyfus currently owns 10,958 shares of IRONWOOD PHARMACEUTICALS INC (IRWD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Dreyfus's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Dreyfus has 23 Form 4 filings on record as an insider at IRONWOOD PHARMACEUTICALS INC.
Set alerts for Andrew Dreyfus and 40,000+ other insiders.